Relativity Logo
    Relativity
    Relativity Logo
    Relativity
    IdeasPortfoliosEvents
    Companies/GRTX

    Galera Therapeutics, Inc.(GRTX)

    Biotechnology
    Rare Disease / Orphan Drug
    BusinessManagementInsider TradingIndustryFinancialsTranscripts
    Company Summary Stats
    H.BearBearishNeutralBullishH.Bull
    50.0
    Insider Trading Score
    Peer Group Scores
    ACGL
    83    GRNQ
    80    GRTX
    50    FFLO
    50    GNPX
    50    GWAV
    50    GRDX
    50    ARTL
    50    BTCY
    50    HG
    36
    Recent Insider Trades
    Filing DateInsiderType10b5-1Net SharesOwnership changeShares ownedAvg. PriceValueFiling
    2025-11-24
    Sorensen Mel
    President and CEO
    Sale
    		-70,000
    -26.41%195,029
    		$0.02$1,407View SEC filing
    2025-01-02
    CHANG NANCY T
    Director, 10% Owner
    Purchase
    		+7,644,932
    +100.00%7,644,932
    		$0.07$499,979View SEC filing
    2024-08-20
    Sorensen Mel
    President and CEO
    Sale
    		-67,015
    -20.18%265,029
    		$0.07$4,825View SEC filing
    2024-05-01
    Schneid Yair
    10% Owner
    Purchase
    		+2,780,407
    +34.57%10,823,610
    		$0.21$590,424View SEC filing
    2024-02-26
    Schneid Yair
    10% Owner
    Purchase
    		+932,402
    +13.11%8,043,203
    		$0.18$166,417View SEC filing
    2023-03-20
    Bachleda Mark
    Chief Commercial Officer
    Purchase
    		+11,000
    +100.00%11,000
    		$2.25$24,717View SEC filing
    2023-03-14
    Sorensen Mel
    President and CEO
    Purchase
    		+100,000
    +43.10%332,044
    		$1.68$168,120View SEC filing
    2023-03-14
    Degnan Chris
    Chief Financial Officer
    Purchase
    		+10,000
    +100.00%10,000
    		$1.96$19,593View SEC filing
    2021-12-20
    West Linda
    Director
    Purchase
    		+20,000
    +50.00%60,000
    		$2.74$54,804View SEC filing
    2021-09-03
    HOLMLUND JON T
    Chief Medical Officer
    Sale
    		-47,756
    -100.00%0
    		$8.47$404,498View SEC filing
    2021-06-17
    West Linda
    Director
    Purchase
    		+10,000
    +33.33%40,000
    		$9.13$91,300View SEC filing
    2021-06-04
    West Linda
    Director
    Purchase
    		+10,000
    +50.00%30,000
    		$8.65$86,511View SEC filing
    2021-06-03
    Alleva Lawrence M
    Director
    Purchase
    		+4,045
    +100.00%4,045
    		$8.59$34,741View SEC filing
    2021-06-02
    West Linda
    Director
    Purchase
    		+20,000
    +100.00%20,000
    		$8.64$172,791View SEC filing
    2021-02-19
    Novo Holdings A/S
    10% Owner
    Sale
    		-500,000
    -16.90%2,459,021
    		$10.58$5,290,000View SEC filing
    2020-11-17
    Alleva Lawrence M
    Director
    Purchase
    		+2,325
    +58.13%6,325
    		$10.22$23,771View SEC filing
    2020-11-16
    Sussman Joel F.
    Chief Accounting Officer
    Sale
    		-20,000
    -100.00%0
    		$10.19$203,824View SEC filing
    2020-10-28
    HOLMLUND JON T
    Chief Medical Officer
    Sale
    		-2,244
    -100.00%0
    		$15.00$33,660View SEC filing
    2020-10-19
    Novo Holdings A/S
    10% Owner
    Sale
    		-450,000
    -13.20%2,959,021
    		$11.00$4,950,000View SEC filing
    2020-10-07
    HOLMLUND JON T
    Chief Medical Officer
    Sale
    		-10,636
    -100.00%0
    		$12.00$127,632View SEC filing
    2020-06-22
    NOVARTIS AG
    Other
    Sale
    		-1,002,212
    -28.88%2,467,961
    		$8.25$8,268,960View SEC filing
    2020-06-17
    NOVARTIS AG
    10% Owner
    Sale
    		-19,386
    -0.56%3,470,173
    		$9.21$178,610View SEC filing
    2020-06-12
    NOVARTIS AG
    10% Owner
    Sale
    		-17,232
    -0.49%3,489,559
    		$9.33$160,810View SEC filing
    2020-06-09
    NOVARTIS AG
    10% Owner
    Sale
    		-21,311
    -0.60%3,506,791
    		$9.57$203,904View SEC filing
    2020-06-04
    NOVARTIS AG
    10% Owner
    Sale
    		-14,965
    -0.42%3,528,102
    		$9.68$144,851View SEC filing

    1-25 of 36

    Page 1 of 2